NCT07450898 Retrospective Analysis of Acute Pancreatitis After Percutaneous Mechanical Thrombectomy In Treatment Of Thrombotic Disorders
| NCT ID | NCT07450898 |
| Status | Recruiting |
| Phase | — |
| Sponsor | RenJi Hospital |
| Condition | Acute Pancreatitis (AP) |
| Study Type | OBSERVATIONAL |
| Enrollment | 10 participants |
| Start Date | 2016-01-01 |
| Primary Completion | 2026-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10 participants in total. It began in 2016-01-01 with a primary completion date of 2026-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Acute pancreatitis is a rare complication after percutaneous mechanical thrombectomy in treatment of thrombotic disorders. The objectives of this study include: (1) Determine the incidence and severity of acute pancreatitis after percutaneous mechanical thrombectomy; (2) Identify patient/procedural risk factors; (3) Evaluate clinical outcomes; (4) Develop a diagnosis and treatment pathway.
Eligibility Criteria
Inclusion Criteria: * Patients over 18 years old; * Patients with thrombotic peripheral vascular diseases treated by percutaneous mechanical thrombectomy; * Patients developed acute pancreatitis within 14 days after percutaneous mechanical thrombectomy; * Patients with written informed consent. Exclusion Criteria: * Patients with acute pancreatitis attributed to other confirmed causes; * Patients unable or unwilling to participate in the study.
Contact & Investigator
Qihong Ni
PRINCIPAL INVESTIGATOR
Department of Vascular Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Frequently Asked Questions
Who can join the NCT07450898 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Pancreatitis (AP). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07450898 currently recruiting?
Yes, NCT07450898 is actively recruiting participants. Contact the research team at niqihong1989@163.com for enrollment information.
Where is the NCT07450898 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT07450898 clinical trial?
NCT07450898 is sponsored by RenJi Hospital. The principal investigator is Qihong Ni at Department of Vascular Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University. The trial plans to enroll 10 participants.